NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Blue Cloud Softech Solutions Sees 6% Intraday Gain on Government Healthcare Project

Market Summary

Shares of Blue Cloud Softech Solutions, a smallcap AI-focused firm, rose up to 6% intraday on Tuesday after the company secured a government healthcare project in Telangana. The stock opened higher at Rs 19.16 per share on the BSE, compared to the previous close of Rs 18.31.

Trading Activity

Read also: SMR Jewels IPO Successfully Lists with Institutional Support

The stock later climbed to an intraday high of Rs 19.50, marking a gain of 6.49%. The scrip settled at Rs 18.97 per share, up 3.6%.

Project Details

In an exchange filing, the company said it has received an order from Central Electronics Ltd (CEL), a Government of India enterprise. The company will deploy its Access Genie AI platform in the Telangana Aarogyasri healthcare system. The scope of the project includes deployment of the AI-based access system, field surveys, and end-customer surveys.

Financial Performance

Read also: Zepto Nears $1 Billion Quarterly Net Order Value Milestone Before IPO

According to BSE Analytics, the stock has delivered a return of 14.07% over five years and 1.92% over one year. On a year-to-date basis, it has declined 2.12%, compared with a 10% fall in the benchmark index.

Investor Takeaway

Investors should consider the potential for small-cap AI firms to benefit from government contracts.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.